Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35303269)

  • 1. SEOM-GEMCAD-TTD clinical guidelines for localized rectal cancer (2021).
    Capdevila J; Gómez MA; Guillot M; Páez D; Pericay C; Safont MJ; Tarazona N; Vera R; Vidal J; Sastre J
    Clin Transl Oncol; 2022 Apr; 24(4):646-657. PubMed ID: 35303269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latest evidence on the management of early-stage and locally advanced rectal cancer: a narrative review.
    Prabhakaran S; Yang TWW; Johnson N; Bell S; Chin M; Simpson P; Carne P; Farmer C; Skinner S; Warrier SK; Kong JC
    ANZ J Surg; 2022 Mar; 92(3):365-372. PubMed ID: 35001464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Li Y; Wang J; Ma X; Tan L; Yan Y; Xue C; Hui B; Liu R; Ma H; Ren J
    Int J Biol Sci; 2016; 12(8):1022-31. PubMed ID: 27489505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 6. Evolution of therapy for locally advanced rectal cancer.
    Altomare NJ; Mulcahy MF
    J Surg Oncol; 2024 Jan; 129(1):78-84. PubMed ID: 38063061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of locally advanced rectal cancer therapy and future prospects.
    Koukourakis IM; Kouloulias V; Tiniakos D; Georgakopoulos I; Zygogianni A
    Crit Rev Oncol Hematol; 2023 Jun; 186():103992. PubMed ID: 37059276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].
    Zhang YQ; Sun KG; Lu JY; Ma J; Yao N; Qin ZH; Yao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun; 25(6):531-538. PubMed ID: 35754218
    [No Abstract]   [Full Text] [Related]  

  • 9. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.
    Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB
    Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advances of optimized neoadjuvant therapy in the treatment of locally advanced rectal cancer].
    Fan J; Zhu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):527-533. PubMed ID: 31238633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Chemotherapy Completion on the Efficacy of Irinotecan in the Preoperative Chemoradiotherapy of Locally Advanced Rectal Cancer: An Expanded Analysis of the CinClare Phase III Trial.
    Wang J; Fan J; Li C; Yang L; Wan J; Zhang H; Zhang Z; Zhu J
    Clin Colorectal Cancer; 2020 Jun; 19(2):e58-e69. PubMed ID: 32265117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer.
    Sada YH; Tran Cao HS; Chang GJ; Artinyan A; Musher BL; Smaglo BG; Massarweh NN
    J Surg Res; 2018 Jun; 226():15-23. PubMed ID: 29661280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curative therapy for rectal cancer.
    Alawawdeh A; Krishnan T; Roy A; Karapetis C; Joshi R; Singhal N; Price T
    Expert Rev Anticancer Ther; 2021 Feb; 21(2):193-203. PubMed ID: 33161803
    [No Abstract]   [Full Text] [Related]  

  • 14. Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all!
    Ozer L; Yildiz I; Bayoglu V; Bozkurt M; Esen E; Remzi FH; Gogenur I; Aytac E
    Colorectal Dis; 2021 Jul; 23(7):1662-1669. PubMed ID: 33829626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Locoregional Rectal Cancer.
    Willett CG
    J Natl Compr Canc Netw; 2018 May; 16(5S):617-619. PubMed ID: 29784739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant radiotherapy for rectal cancer management.
    Feeney G; Sehgal R; Sheehan M; Hogan A; Regan M; Joyce M; Kerin M
    World J Gastroenterol; 2019 Sep; 25(33):4850-4869. PubMed ID: 31543678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
    Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
    BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study.
    Yu X; Wang QX; Xiao WW; Chang H; Zeng ZF; Lu ZH; Wu XJ; Chen G; Pan ZZ; Wan DS; Ding PR; Gao YH
    Cancer Commun (Lond); 2018 May; 38(1):24. PubMed ID: 29784042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.